Leadership

Alvion Bio formalises leadership team as it scales Revalyxis™ platform

Alvion Bio AB, the Lund-based supplier of amniotic fluid-derived mesenchymal stem cells (AF-MSCs), today confirmed its executive leadership team, with five of its founders stepping into formal roles as the company scales its Revalyxis™ cell platform. Justin Pierce takes the role of Chairman and Chief Commercial Officer, Fredrik Andersson becomes Chief Executive Officer, Dr Marcus Larsson Chief Scientific Officer, Dr Andreas Herbst Chief Medical Officer, and Megi Medzmariashvili Chief Legal Counsel and Regulatory.